AspenBio Pharma
Founded Year
2000Stage
PIPE - II | IPOTotal Raised
$2.53MAbout AspenBio Pharma
AspenBio Pharma is a Healthcare/Biotechnology company based in Castle Rock, Colorado. AspenBio Pharma's investors include Joshua Tree Asset Management, HealthCor Management, Corriente Advisors, Iroquois Capital and Ardsley Partners.
Missing: AspenBio Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: AspenBio Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
AspenBio Pharma Patents
AspenBio Pharma has filed 8 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/4/2004 | 10/23/2018 | Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors | Grant |
Application Date | 3/4/2004 |
|---|---|
Grant Date | 10/23/2018 |
Title | |
Related Topics | Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors |
Status | Grant |
Latest AspenBio Pharma News
Nov 29, 2016
Advertisement Topics Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 07:24 EST 29 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. since January 2007. Key Findings Provides intelligence on Venaxis, Inc. formerly AspenBio Pharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Venaxis, Inc. formerly AspenBio Pharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Venaxis, Inc. formerly AspenBio Pharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News
AspenBio Pharma Frequently Asked Questions (FAQ)
When was AspenBio Pharma founded?
AspenBio Pharma was founded in 2000.
Where is AspenBio Pharma's headquarters?
AspenBio Pharma's headquarters is located at 1585 South Perry Street, Castle Rock.
What is AspenBio Pharma's latest funding round?
AspenBio Pharma's latest funding round is PIPE - II.
How much did AspenBio Pharma raise?
AspenBio Pharma raised a total of $2.53M.
Who are the investors of AspenBio Pharma?
Investors of AspenBio Pharma include Iroquois Capital Group, Joshua Tree Asset Management, Corriente Advisors, HealthCor Management, Ardsley Partners and 3 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.